APO RESEARCH · REPORT
Biomarkers
In biological system, it means to calculate the whole number by marking part of individuals.
Product & engineering
Understand the product.
In biological system, it means to calculate the whole number by marking part of individuals.
Selected research
Industry Growth & Trends
Global Biomarkers Industry Growth and Trends Forecast to 2032
Market perspective
In biological system, it means to calculate the whole number by marking part of individuals.
According to APO Research, the global Biomarkers market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
Report Scope
Read the full market overview
This report provides a structured, data-driven view of the global Biomarkers market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Biomarkers market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Biomarkers market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Biomarkers.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Biomarkers market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Biomarkers Market by Company
Thermo Fisher Scientific
Merck
Bio-Rad Laboratories
QIAGEN
Roche
Danaher Corporation
Siemens Healthcare
Abbott
Agilent Technologies
Biomarkers Segment by Type
Sepsis Biomarkers
Antibiotic Resistance Biomarkers
Traumatic Brain Injury (TBI) Testing Biomarkers
Stroke Testing Biomarkers
Antibiotic Stewardship Biomarkers
Other
Biomarkers Segment by Application
Diagnostics
Drug Discovery
Personalized Medicine
Other
Biomarkers Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biomarkers market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Biomarkers and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biomarkers.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Biomarkers companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Sepsis Biomarkers
- Antibiotic Resistance Biomarkers
- Traumatic Brain Injury (TBI) Testing Biomarkers
- Stroke Testing Biomarkers
- Antibiotic Stewardship Biomarkers
- Other
Applications
- Diagnostics
- Drug Discovery
- Personalized Medicine
- Other
Companies covered
- Thermo Fisher Scientific
- Merck
- Bio-Rad Laboratories
- QIAGEN
- Roche
- Danaher Corporation
- Siemens Healthcare
- Abbott
- Agilent Technologies
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Biomarkers Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Biomarkers Market Size by Region (2021-2032)
- 1.4.1 Global Biomarkers Market Size by Region (2021-2026)
- 1.4.2 Global Biomarkers Market Size by Region (2027-2032)
- 1.5 Key Regions Biomarkers Market Size (2021-2032)
- 1.5.1 North America Biomarkers Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Biomarkers Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Biomarkers Market Size Growth Rate (2021-2032)
- 1.5.4 South America Biomarkers Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Biomarkers Market Size Growth Rate (2021-2032)
2 Biomarkers Market by Type
- 2.1 Type Introduction
- 2.1.1 Sepsis Biomarkers
- 2.1.2 Antibiotic Resistance Biomarkers
- 2.1.3 Traumatic Brain Injury (TBI) Testing Biomarkers
- 2.1.4 Stroke Testing Biomarkers
- 2.1.5 Antibiotic Stewardship Biomarkers
- 2.1.6 Other
- 2.2 Global Biomarkers Market Size by Type
- 2.2.1 Global Biomarkers Market Size Overview by Type (2021-2032)
- 2.2.2 Global Biomarkers Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Biomarkers Market Size Forecasted by Type (2027-2032)
- 2.3 Global Biomarkers Market Size by Regions
- 2.3.1 North America Biomarkers Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Biomarkers Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Biomarkers Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Biomarkers Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Biomarkers Market Size Breakdown by Type (2021-2026)
3 Biomarkers Market by Application
- 3.1 Type Introduction
- 3.1.1 Diagnostics
- 3.1.2 Drug Discovery
- 3.1.3 Personalized Medicine
- 3.1.4 Other
- 3.2 Global Biomarkers Market Size by Application
- 3.2.1 Global Biomarkers Market Size Overview by Application (2021-2032)
- 3.2.2 Global Biomarkers Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Biomarkers Market Size Forecasted by Application (2027-2032)
- 3.3 Global Biomarkers Market Size by Regions
- 3.3.1 North America Biomarkers Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Biomarkers Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Biomarkers Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Biomarkers Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Biomarkers Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Biomarkers Industry Trends
- 4.2 Biomarkers Industry Drivers
- 4.3 Biomarkers Industry Opportunities and Challenges
- 4.4 Biomarkers Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Biomarkers Revenue (2021-2026)
- 5.2 Global Biomarkers Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Biomarkers Key Company Headquarters & Area Served
- 5.4 Global Biomarkers Company, Product Type & Application
- 5.5 Global Biomarkers Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Biomarkers Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Biomarkers Players Market Share by Revenue in 2025
- 5.6.3 2025 Biomarkers Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Thermo Fisher Scientific
- 6.1.1 Thermo Fisher Scientific Company Information
- 6.1.2 Thermo Fisher Scientific Business Overview
- 6.1.3 Thermo Fisher Scientific Biomarkers Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Thermo Fisher Scientific Biomarkers Product Portfolio
- 6.1.5 Thermo Fisher Scientific Recent Developments
- 6.2 Merck
- 6.2.1 Merck Company Information
- 6.2.2 Merck Business Overview
- 6.2.3 Merck Biomarkers Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Merck Biomarkers Product Portfolio
- 6.2.5 Merck Recent Developments
- 6.3 Bio-Rad Laboratories
- 6.3.1 Bio-Rad Laboratories Company Information
- 6.3.2 Bio-Rad Laboratories Business Overview
- 6.3.3 Bio-Rad Laboratories Biomarkers Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Bio-Rad Laboratories Biomarkers Product Portfolio
- 6.3.5 Bio-Rad Laboratories Recent Developments
- 6.4 QIAGEN
- 6.4.1 QIAGEN Company Information
- 6.4.2 QIAGEN Business Overview
- 6.4.3 QIAGEN Biomarkers Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 QIAGEN Biomarkers Product Portfolio
- 6.4.5 QIAGEN Recent Developments
- 6.5 Roche
- 6.5.1 Roche Company Information
- 6.5.2 Roche Business Overview
- 6.5.3 Roche Biomarkers Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Roche Biomarkers Product Portfolio
- 6.5.5 Roche Recent Developments
- 6.6 Danaher Corporation
- 6.6.1 Danaher Corporation Company Information
- 6.6.2 Danaher Corporation Business Overview
- 6.6.3 Danaher Corporation Biomarkers Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Danaher Corporation Biomarkers Product Portfolio
- 6.6.5 Danaher Corporation Recent Developments
- 6.7 Siemens Healthcare
- 6.7.1 Siemens Healthcare Company Information
- 6.7.2 Siemens Healthcare Business Overview
- 6.7.3 Siemens Healthcare Biomarkers Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 Siemens Healthcare Biomarkers Product Portfolio
- 6.7.5 Siemens Healthcare Recent Developments
- 6.8 Abbott
- 6.8.1 Abbott Company Information
- 6.8.2 Abbott Business Overview
- 6.8.3 Abbott Biomarkers Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 Abbott Biomarkers Product Portfolio
- 6.8.5 Abbott Recent Developments
- 6.9 Agilent Technologies
- 6.9.1 Agilent Technologies Company Information
- 6.9.2 Agilent Technologies Business Overview
- 6.9.3 Agilent Technologies Biomarkers Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 Agilent Technologies Biomarkers Product Portfolio
- 6.9.5 Agilent Technologies Recent Developments
7 North America
- 7.1 North America Biomarkers Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Biomarkers Market Size by Country (2021-2026)
- 7.3 North America Biomarkers Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Biomarkers Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Biomarkers Market Size by Country (2021-2026)
- 8.3 Europe Biomarkers Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Biomarkers Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Biomarkers Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Biomarkers Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Biomarkers Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Biomarkers Market Size by Country (2021-2026)
- 10.3 South America Biomarkers Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Biomarkers Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Biomarkers Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Biomarkers Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst